Blog — analysis, comparisons & consumer guidance

Pricing

• How to Read Compounded GLP-1 Pricing Without Getting Fooled
  The cheapest-looking option is usually the most expensive. Here is how to see the real number.
• Compounded vs Brand-Name GLP-1 Cost in 2026: An Honest Comparison
  Different regulatory standing, different risk, different cost. Comparing them fairly means not ranking them together.
• Effective Monthly Cost: The Number That Compares Providers
  Providers quote incompatible numbers on purpose. One metric fixes that.
• The Hidden Cost of GLP-1 Membership Fees
  A $99 medication with a $79 membership is a $178 program. Here's how the model works.
• Are Prepaid GLP-1 Plans Worth It? Running the Real Numbers
  The discount is real. So is the money at risk if your situation changes.
• Dose Surcharges: Why Your GLP-1 Price Can Climb as You Titrate
  The price you start at often isn't the price you settle at.
• First-Month vs Renewal Pricing: The Introductory-Offer Trap
  You'll pay the renewal price far more often than the first-month price.
• Compounded Tirzepatide Cost: A 2026 Buyer's Guide
  Tirzepatide floors run above semaglutide at the same providers. Here's the current picture.
• Compounded Semaglutide Cost: A 2026 Buyer's Guide
  The legitimate floor firmed up in 2026. Here's what real pricing looks like.
• All-Inclusive vs Membership GLP-1 Models: Which Costs Less?
  Neither model is always cheaper. It depends on your dose and how long you stay.

Safety

• How to Verify Your Compounding Pharmacy in 15 Minutes
  The pharmacy, not the brand, determines what arrives at your door. Verify it.
• 503A vs 503B: What the Difference Means for Your Medication
  One is state-overseen, one is FDA-registered. Neither means the product is approved.
• Semaglutide Salt Forms: A Risk Regulators Have Flagged
  FDA has warned about salt forms. You can't tell from a label that says only 'semaglutide.'
• GLP-1 Dosing Errors: Why Concentration Changes Are Dangerous
  Units measure volume, not drug. When concentration changes, the math changes.
• Counterfeit Semaglutide: The Red Flags That Should Stop You
  No prescription, no named pharmacy, implausibly low price — that's not a bargain.
• Your GLP-1 Arrived Warm: What to Do
  Don't assume warm means ruined or fine. Document it and ask the pharmacy.
• Beyond-Use Dates on Multi-Month GLP-1 Plans
  A twelve-month plan is only as useful as the beyond-use dates on the vials shipped.
• How to Read a Pharmacy Warning Letter
  An allegation-and-notice stage, not a final verdict. Read the details before deciding.

Clinical

• GLP-1 Microdosing: What the Evidence Actually Says
  A commercial category, not a clinical one. Here's what that means for you.
• Does Compounded Oral Semaglutide Actually Work?
  The core question — does enough drug get in — is usually unanswered for compounded oral products.
• Semaglutide vs Tirzepatide: How the Two Compare
  Two receptors versus one, different trial outcomes, different prices. A clinical decision, not a shopping one.
• GLP-1 Weight Regain After Stopping: What Studies Show
  The evidence suggests weight often returns after stopping. That reframes the cost question.
• Lean Mass and GLP-1s: What the Evidence Suggests
  Not all lost weight is fat. Here's what the research suggests and where it's uncertain.

Consumer

• 12 Questions to Ask a GLP-1 Provider Before You Pay
  Transparency shows in specifics. Here are the specifics to demand.
• GLP-1 Telehealth Red Flags: When to Walk Away
  A single flag isn't proof. Several together describe a seller to avoid.
• GLP-1 Cancellation and Refund Terms: Read Before You Prepay
  The prepaid discount means nothing if you can't get out. Get the terms in writing.
• Insurance, HSA, and FSA for Compounded GLP-1s: What Applies
  Coverage is rare; tax-advantaged spending is common. Know the difference.
• Why GLP-1 Telehealth Availability Varies by State
  A provider licensed to ship to your neighbor may not be licensed to ship to you.
• The Evidence-Based GLP-1 Shopping Checklist
  Everything this site teaches, condensed into one pre-purchase routine.

Regulatory

• The GLP-1 Shortage Is Over: What That Means for Compounding
  The legal basis for broad compounding narrowed. Access now hinges on documented clinical need.
• FDA Enforcement and Compounded GLP-1 Marketing in 2026
  The enforcement environment is active. Here's how to read it without overclaiming.
• 'Not FDA Approved' — What It Actually Means for Compounded GLP-1s
  Not approved means not premarket-reviewed. It's a real distinction, not a scare word.